• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT); OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT); OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*RX25RW
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/31/2022
Event Type  malfunction  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual device was not returned for evaluation.Detailed investigation could not be conducted because the actual sample was not returned.Ashitaka factory has experienced air inclusion in the oxygenator under the following conditions in the past: when the roller pump was suddenly stopped during priming, the pressure inside the oxygenator became negative and air was drawn through the fiber.Considering this, the simulation test using a sample from the same product code was performed as follows.Colored physiological saline solution was circulated at 4 l/min, which was the same flow rate as mentioned in the complaint, and then the roller pump was stopped suddenly.As a result, the pressure inside the oxygenator became negative (approximal 20 mmhg, which was measured at the sampling line), and air inclusion occurred.(note: the negative pressure applied to the oxygenator when the roller pump is stopped suddenly varies depending on the circulatory conditions and circuit specifications.Review of the manufacturing record and product-release judgement record of the involved product code/lot number combination confirmed there was no indication of anomaly in them.A search of the complaint file found no other similar reports with the involved product code/lot number combination.Based on the provided additional information and the results of the simulation test, as one possible cause of this issue, it was inferred that the air was drawn in the oxygenator through the fiber due to the negative pressure generated inside the oxygenator when the roller pump was suddenly stopped.However, since the actual sample was not returned for analysis, the cause of occurrence could not be clarified.It was presumed that, when the roller pump was stopped suddenly or clamping operation was performed, though the inflow of the priming solution into the oxygenator stopped, the outflow from the oxygenator continued due to inertia, which resulted in the negative pressure inside the oxygenator.Relevant ifu (instructions for use) reference: "during recirculation, do not use pulsatile flow and do not stop the blood pump suddenly as these actions may cause gaseous emboli to enter the blood phase from the gas phase due to inertia force." "pressure in the blood phase should always be higher than that in the gas phase to prevent gaseous emboli entering the blood phase." (b)(4).
 
Event Description
The user facility reported that at the time of priming the oxygenator with crystalloid fluid, the air bubbles were consistently seen over the membrane of the rx25 oxygenator even after priming and recirculating it for the significant time.The bubbles kept arising from the bottom of the oxy travelling to the top and eventually entering the arterial line of the circuit.However, it was observed that the bubbles were formed when the pump was stopped abruptly and with gradual reduction of the pump speed, bubbles were not to be seen.The oxygenator was not replaced, and the procedure was continued as normal.The event had no impact on the functioning of the oxygenator throughout the procedure.There was no patient involvement when the event occurred.The event occurred pre-treatment.The patient's final impact was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT)
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
stephanie handy
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
9499890491
MDR Report Key14205194
MDR Text Key290062785
Report Number9681834-2022-00071
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350769572
UDI-Public04987350769572
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K040210
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCX*RX25RW
Device Lot Number211029
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age37 YR
Patient SexMale
Patient Weight66 KG
-
-